1. Introduction {#sec1-jcm-09-01271}
===============

Preeclampsia is a disorder that complicates up to 7% of all pregnancies and is a leading cause of morbidity and mortality of both mother and fetus \[[@B1-jcm-09-01271],[@B2-jcm-09-01271]\]. Throughout the years, many hypotheses have been proposed to explain the pathophysiological mechanism underlying preeclampsia. One leading hypothesis suggests that an impairment in the placentation process leads to a hypoxic placental state, which triggers a systemic endothelial dysfunction and consequently affects various body systems \[[@B3-jcm-09-01271],[@B4-jcm-09-01271]\].

An alternative hypostasis endorses that the manifestation of preeclampsia is predisposed by impaired cardiovascular conditions in the mother. As the pregnancy becomes increasingly demanding, the failure of the cardiovascular system to properly adapt subsequently leads to a secondary placentation dysfunction, which in turn leads to the development of preeclampsia and systemic endothelial dysfunction \[[@B5-jcm-09-01271],[@B6-jcm-09-01271]\].

Nevertheless, it is widely agreed that the abnormal development of the placenta stands at the core of the pathophysiology of preeclampsia. Impaired placentation leads to placental hypoxia, which subsequently increases the expression of hypoxia-inducible factor-1 (HIF-1), a transcription factor that plays a central role in the induction of systemic endothelial dysfunction in both the mother and the fetus \[[@B4-jcm-09-01271],[@B7-jcm-09-01271],[@B8-jcm-09-01271]\]. This pathological endothelial state consequently affects distant tissues and body systems in both the mother and the fetus, including cardiovascular, renal, hepatic, neurological and visual systems, as up to 25% of mothers with severe preeclampsia suffer from visual symptoms \[[@B3-jcm-09-01271],[@B9-jcm-09-01271],[@B10-jcm-09-01271],[@B11-jcm-09-01271],[@B12-jcm-09-01271],[@B13-jcm-09-01271]\].

Studies have found that the repercussions of the systemic endothelial dysfunction of preeclampsia continue to have an affect years after delivery \[[@B14-jcm-09-01271]\]. Women with a history of preeclampsia were predisposed to several long-term maternal vascular morbidities, such as cardiovascular, renal and chronic hypertension \[[@B10-jcm-09-01271],[@B15-jcm-09-01271],[@B16-jcm-09-01271]\]. A recent study has also found a significant risk for long-term vascular ophthalmic morbidities, such as diabetic retinopathy and retinal detachment \[[@B17-jcm-09-01271]\]. This knowledge has recently led the International Federation of Gynecology and Obstetrics (FIGO) to recommend the follow-up of all women with preeclampsia 6--12 weeks after birth, and periodically thereafter, with screenings for hypertensive disorders and cardiovascular risk factors \[[@B18-jcm-09-01271]\].

As for the offspring, the hypoxic condition of the placenta causes great stress to the intrauterine environment and poses a significant risk for immediate neonatal morbidity and mortality \[[@B19-jcm-09-01271],[@B20-jcm-09-01271]\]. The definitive treatment of preeclampsia is the delivery of the fetus, therefore it is considered to be a leading cause of preterm delivery that results in low birth weight and short-term visual morbidity, such as retinopathy of prematurity (ROP) \[[@B19-jcm-09-01271],[@B21-jcm-09-01271]\].

Several hypotheses suggest that preeclamptic intrauterine stress triggers an adaptive epigenetic programming reaction in the fetus that permanently alters gene expression and increases the susceptibility of the child to vascular diseases later in life \[[@B20-jcm-09-01271],[@B22-jcm-09-01271],[@B23-jcm-09-01271],[@B24-jcm-09-01271]\]. Offspring who were prenatally exposed to preeclampsia have an increased risk for long-term vascular morbidities, such as chronic hypertension, stroke and cardiovascular diseases \[[@B10-jcm-09-01271],[@B22-jcm-09-01271],[@B23-jcm-09-01271],[@B25-jcm-09-01271]\].

The short-term ophthalmic complications of preeclampsia for both mother \[[@B11-jcm-09-01271],[@B13-jcm-09-01271]\] and child \[[@B19-jcm-09-01271]\] have been previously described in the literature, focusing mostly on retinopathy of prematurity of the offspring. While recent studies addressed the long-term ophthalmic morbidity in women with a history of preeclampsia \[[@B17-jcm-09-01271]\], knowledge of the long-term ophthalmic morbidities in the offspring is yet to be established. This gap of knowledge is mainly due to a lack of published data regarding the long-term ophthalmic consequences in children up to the age of 18, who were born to mothers with preeclampsia. Being a multisystem vascular disorder, we proposed a hypothesis that the visual system of the offspring (regardless of gestational age) is also affected by the long-term outcomes of preeclampsia. The purpose of this population-based study was to evaluate whether preeclampsia poses a risk for long-term ophthalmic morbidity in the offspring.

2. Experimental Section {#sec2-jcm-09-01271}
=======================

This retrospective population-based cohort study was based on non-selective population data, as it was conducted at Soroka University Medical Center (SUMC), a sole tertiary medical center that serves the population of the Negev region in Israel, a region that spans the entire southern half of the State of Israel. The study protocol was approved by the institutional review board (SUMC IRB Committee), in accordance with the Helsinki declaration and informed consent was exempt. All singleton deliveries between the years 1991 and 2014 were included in the study population. Exclusion criteria were multiple gestations, perinatal mortality and offspring with congenital and chromosomal abnormalities.

The study compared offspring who were prenatally exposed to preeclampsia and those who were not. The exposure to preeclampsia was divided into two categories based on the severity: mild preeclampsia (International Classification of Disease, 9th revision (ICD-9) codes 64242, 64241) versus severe preeclampsia (ICD-9 codes 64252, 64251) and eclampsia (ICD-9 codes 64261, 64262). Due to the small number of cases of eclampsia, (*n* = 75) it was included in the severe preeclampsia category. The severity of preeclampsia was classified according to the guidelines of the Working Group of the National High Blood Pressure Education Program \[[@B26-jcm-09-01271]\].

The main outcome was subsequent offspring ophthalmic morbidity. Thus, we conducted a retrospective follow-up of offspring up to the age of 18 years who were hospitalized due to ophthalmic conditions. The follow-up time started immediately after their release from hospital and was defined as time to an event (first hospitalization due to ophthalmic condition), or until censored in the case of mortality or at the age of 18 years. Ophthalmic hospitalizations were defined in accordance with the International Classification of Disease, 9th revision (ICD-9), and included conditions such as visual disturbance, ophthalmic infection, inflammation and retinopathy of prematurity (ROP) documented at SUMC (see [Table A1](#jcm-09-01271-t0A1){ref-type="table"} and [Table S1](#app1-jcm-09-01271){ref-type="app"}). The data collected were the result of merging and crosslinking between two different databases. The first set of data was based on the collection of computerized perinatal data that had previously been recorded at the delivery stage by the obstetrician. The second database was based on the collection of pediatric hospitalization records at SUMC. This computerized database included both demographic information and all medical diagnoses that were made during hospitalizations at SUMC, and were classified under the ICD-9 codes. Following delivery, all offspring were issued with a national security ID assigned by the state. These ID numbers were also registered under the mother's identification card. Entering both mother and offspring ID numbers allowed us to track and link the relationship between mother and offspring in our database.

Statistical Analysis
--------------------

We performed a statistical analysis using the SPSS package, version 23 (IBM/SPSS, Chicago, IL, USA). Chi-square and analysis of variance (ANOVA) tests were used to identify statistical differences for general association. Continuous variables with normal distribution (maternal age and gestational age) were presented in years as mean ± standard deviation (SD) and were evaluated using one-way ANOVA test. Categorical variables with non-normal distribution (parity, preterm delivery, low birth weight, ethnicity and Apgar score) were presented in percentages and were evaluated using a Pearson chi square test. The categories were defined as accepted in the prenatal literature. Parity was categorized into three categories (1, 2--4, 5+) in order to reflect both nulliparity and grand multiparity, as it is known to have a clinical effect \[[@B27-jcm-09-01271]\]. Apgar was categorized into two categories: greater than or equal to seven points and less than seven points, in accordance with its clinical significance \[[@B28-jcm-09-01271]\]. Birth weight was categorized into two categories: greater than or equal to 2500 g, and less than 2500 g, in accordance with its clinical significance. Since preterm delivery is a major outcome in preeclampsia, we entered gestational age not only as a continued variable, but also as a categorical variable (i.e., preterm before 37 or before 34 week of gestation).

The date of the first hospitalization was used to specifically calculate time-to-event in the survival analysis and to compare the differences in incidence between the study groups. Both Kaplan--Meier curves and Cox proportional hazard regression models were used in our study to detect the univariate and multivariable analyses. The cumulative ophthalmic hospitalization incidence over time was analyzed using a univariate statistical analysis performed by the Kaplan--Meier survival curve estimation. A multivariable Cox proportional hazard regression model was fit to estimate the associations between preeclampsia and long-term ophthalmic hospitalizations, while controlling for statistically significant and clinically important confounders. Maternal age and ethnicity were defined as confounders and were included in the final presented models. Maternal age is a clinically important risk factor for adverse perinatal outcome \[[@B29-jcm-09-01271]\]. Additionally, ethnicity is a strong marker that highly correlates with socioeconomic status. The ethnic diversity of the two socioeconomic societies inhabiting the southern part of Israel, Jewish and Bedouins, represents a wider difference in the utilization of healthcare services, degree of income and access to resources \[[@B30-jcm-09-01271],[@B31-jcm-09-01271]\]. From the models, the hazard ratio (HR) and 95% confidence interval (CI) as the effect measure were derived. The proportionality of the variables in the models was evaluated by visualization of the Kaplan--Meier graphs of each of the variables. A *p*-value of \< 0.05 was considered statistically significant.

3. Results {#sec3-jcm-09-01271}
==========

A total of 242,342 deliveries were documented during the study period ([Figure 1](#jcm-09-01271-f001){ref-type="fig"}). After excluding perinatal morbidities (*n* = 1340), congenital and chromosomal abnormalities (*n* = 6150) and multifetal pregnancies (twins or triplets) (*n* = 11,454), 7279 (3%) cases were diagnosed with mild preeclampsia and 2222 (0.92%) with severe preeclampsia or eclampsia. The median follow-up time was 10.4 years in the no preeclampsia group, and 11.7 and 11.4 years in the severe preeclampsia or eclampsia group, respectively. During the follow-up time, 52,000 cases reached the age of 18 years and thus were defined as censored. The characteristics of the study population, based on the severity of preeclampsia, are shown in [Table 1](#jcm-09-01271-t001){ref-type="table"}. Women diagnosed with preeclampsia were significantly older when compared to the no preeclampsia (PE) group (no PE 28.13 ± 5.79 vs. mild PE 28.66 ± 6.31 vs. severe PE or eclampsia 29.00 ± 6.94, *p* \< 0.001). The rate of nulliparity was significantly higher among the mild and severe preeclampsia groups (no PE 22.9% vs. Mild PE 39.2% vs. Severe PE or eclampsia 43.4%, *p* \< 0.001). Higher rates of preterm delivery (no PE 6.1% vs. mild PE 9.6% vs. severe PE or eclampsia 43.4%, *p* \< 0.001) and low birth weight (no PE 5.9% vs. mild PE 10.6% vs. severe PE or eclampsia 46.2%, *p* \< 0.001) were noted in offspring in the preeclampsia groups.

[Table 2](#jcm-09-01271-t002){ref-type="table"} presents the incidence of long-term ophthalmic morbidities between the study groups. Significant differences were noted between offspring prenatally exposed to preeclampsia (no preeclampsia, mild and severe preeclampsia) and long-term vascular-associated ophthalmic morbidities (0.3%, vs. 0.2% vs. 0.5% respectively, *p*-value = 0.008).

[Figure 2](#jcm-09-01271-f002){ref-type="fig"} demonstrates the Kaplan--Meier survival curves for the cumulative incidence of long-term total ophthalmic hospitalization among the three study groups (no preeclampsia, mild preeclampsia and severe preeclampsia or eclampsia). The difference between the study groups was not statistically significant (Log-rank test, *p* = 0.118).

[Figure 3](#jcm-09-01271-f003){ref-type="fig"} presents individual Kaplan--Meier curves to illustrate the cumulative incidence among the study groups for the following individual outcomes: vascular and other ([Figure 3](#jcm-09-01271-f003){ref-type="fig"}A), visual disturbance ([Figure 3](#jcm-09-01271-f003){ref-type="fig"}B) and infection and inflammation ([Figure 3](#jcm-09-01271-f003){ref-type="fig"}C). Prenatal exposure to severe preeclampsia was noted as a significant risk factor for vascular-associated ophthalmic hospitalization ([Figure 3](#jcm-09-01271-f003){ref-type="fig"}A, Log-rank test, *p* = 0.007).

[Table 3](#jcm-09-01271-t003){ref-type="table"} presents Cox regression models estimation that were used to examine an independent association between long-term ophthalmic morbidity of the offspring based on the exposure status. After controlling for maternal age and ethnicity, which were defined as confounders, prenatal exposure to severe preeclampsia or eclampsia was found to be a significant risk factor for vascular-associated ophthalmic morbidities in the offspring later in life (adjusted HR 1.861, 95% CI 1.051--3.295).

4. Discussion {#sec4-jcm-09-01271}
=============

Preeclampsia is a pregnancy-specific syndrome with multisystem involvement that increases the risk for vascular diseases in both a mother and her offspring \[[@B23-jcm-09-01271]\]. The main goal of our study was to further investigate whether preeclampsia poses a risk for long-term ophthalmic morbidity in the offspring. The major findings of our study indicate that, in our population, severe preeclampsia or eclampsia were found to be a significant risk factor for long-term vascular-associated ophthalmic morbidity in offspring. Our findings are supported by several studies which have previously described the relationship between the severity of preeclampsia and long-term vascular morbidities (i.e., cardiovascular, renal) in relation to the mother \[[@B16-jcm-09-01271]\] and the fetus \[[@B22-jcm-09-01271]\]. Nevertheless, in our population, mild preeclampsia was not found to be a risk factor for long-term vascular-associated ophthalmic morbidity in the offspring. Additional research is required in order to further investigate these findings.

Many hypotheses have been proposed to explain the pathophysiological mechanisms by which preeclampsia increases the susceptibility for long-term morbidity in the offspring. Even so, our current understanding regarding these mechanisms is still limited. In concurrence with the Fetal Origins Hypothesis (also known as "Barker's Hypothesis"), one hypothesis suggests that the hypoxic intrauterine environment triggers adaptive reactions in the fetus that might play a key role in the development of the long-term consequences of preeclampsia. The hypothesis explains that the stressed intrauterine environment leads to profound epigenetic programming that results in altered regulatory gene expression and impaired transcriptional activity in the fetus. This effect seems to extend into adulthood and permanently increases the susceptibility of the child to vascular morbidity later in life. The hypothesis is supported by various recent studies that have found preeclampsia to be an independent risk factor for long-term vascular morbidities, such as cardiovascular morbidity and a higher risk of hypertension \[[@B10-jcm-09-01271],[@B22-jcm-09-01271],[@B23-jcm-09-01271],[@B24-jcm-09-01271],[@B32-jcm-09-01271],[@B33-jcm-09-01271]\].

The main strength of our population-based study is that our hospital provided both ophthalmological and obstetrical services to the entire population of southern Israel, as it serves as the sole hospital of the entire region. Additionally, the registration methodology in our databases allowed us to easily track and link the relationship between mothers and their offspring. Both strengths provided us with longitudinal data from a large cohort and allowed us to compare between different groups, based on the severity of the preeclampsia.

Nevertheless, several limitations of the study should be noted. Firstly, due to the lack of data on immigration in our study, patients who withdrew from the study before the end of the follow-up period were not counted in the study. In any case, there is no reason to suspect differential rates of outcome ascertainment in the study groups, as we can reasonably assume that such withdrawal was relatively equal in all study groups. Secondly, due to the retrospective nature of the study, only ophthalmic morbidities that resulted in hospitalization were recorded in our database. Therefore, it is reasonable to assume that most ophthalmic morbidities were treated in an outpatient setting. Generalizability can be addressed as one of the potential limitations of the study, as only ophthalmic morbidities that resulted in hospitalization were recorded in our database. The external validity of our findings may be limited to the severe cases of ophthalmic morbidities, those requiring hospitalization, and not to all ophthalmic morbidities, which are generally treated in an outpatient setting. However, due to the wide geographical area served by Soroka University Medical Center (SUMC), and the fact that all health services are fully covered by law for all citizens, there is no reason to assume that offspring requiring hospitalization would not show up to be treated at SUMC. Importantly, this is a large population-based study, so our finding can be useful and representative of the severe morbidities in other populations.

In addition, the rate of pediatric ophthalmic morbidity was significantly low (1.0%, *n* = 2330), as only severe cases requiring hospitalization were entered into our study. Therefore, despite our large sample size, our findings were limited to relatively small numbers of cases of ophthalmic hospitalization that were available to analyze, with limited statistical power to detect the effects on specific ophthalmic morbidities. Nevertheless, we were able to find significant difference between mild and severe preeclampsia and vascular-associated ophthalmic morbidity.

5. Conclusions {#sec5-jcm-09-01271}
==============

In conclusion, the present results of our study suggest that there is a significant association between prenatal exposure to severe preeclampsia or eclampsia and long-term vascular-associated ophthalmic morbidity in the offspring. Further studies are needed to determine the association between mild preeclampsia and the development of long-term vascular-associated ophthalmic morbidity in the offspring.
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jcm-09-01271-t0A1_Table A1

###### 

ICD-9 Codes Used.

  Groups                       Diagnostic Codes                                                 Diagnosis Description
  ---------------------------- ---------------------------------------------------------------- -------------------------------------
  Infection and Inflammation   370                                                              Keratitis
  3709                         Unspecified keratitis                                            
  3720                         Acute conjunctivitis                                             
  3723                         Other and unspecified conjunctivitis                             
  3729                         Unspecified disorders of conjunctiva                             
  3732                         Chalazion                                                        
  3736                         Parasitic infestation of eyelid                                  
  3739                         Unspecified inflammation of eyelid                               
  37021                        Punctate keratitis                                               
  37031                        Phlyctenular keratoconjunctivitis                                
  37040                        Keratoconjunctivitis, unspecified                                
  37049                        Other keratoconjunctivitis                                       
  37055                        Corneal abscess                                                  
  37059                        Other interstitial and deep keratitis                            
  37200                        Acute conjunctivitis, unspecified                                
  37202                        Acute follicular conjunctivitis                                  
  37203                        Other mucopurulent conjunctivitis                                
  37205                        Acute atopic conjunctivitis                                      
  37213                        Vernal conjunctivitis                                            
  37214                        Other chronic allergic conjunctivitis                            
  37220                        Blepharoconjunctivitis, unspecified                              
  37230                        Conjunctivitis, unspecified                                      
  37240                        Pterygium, unspecified                                           
  37261                        Granuloma of conjunctiva                                         
  37300                        Blepharitis, unspecified                                         
  37311                        Hordeolum externum                                               
  37312                        Hordeolum internum                                               
  37313                        Abscess of eyelid                                                
  37400                        Entropion, unspecified                                           
  37502                        Chronic dacryoadenitis                                           
  37530                        Dacryocystitis, unspecified                                      
  37532                        Acute dacryocystitis                                             
  37541                        Chronic canaliculitis                                            
  37542                        Chronic dacryocystitis                                           
  37543                        Lacrimal mucocele                                                
  37600                        Acute inflammation of orbit, unspecified                         
  37601                        Orbital cellulitis                                               
  37610                        Chronic inflammation of orbit, unspecified                       
  37611                        Orbital granuloma                                                
  37612                        Orbital myositis                                                 
  37730                        Optic neuritis, unspecified                                      
  37739                        Other optic neuritis                                             
  376010                       Periorbital cellulitis                                           
  Retinopathy of Prematurity   36221                                                            Retrolental Fibroplasia
  362211                       Retinopathy of prematurity                                       
  Visual Disturbances          3688                                                             Other specified visual disturbances
  3689                         Unspecified visual disturbance                                   
  3699                         Unspecified visual loss                                          
  3780                         Esotropia                                                        
  36900                        Blindness of both eyes, impairment level not further specified   
  36960                        Blindness, one eye, not otherwise specified                      
  36970                        Low vision, one eye, not otherwise specified                     
  37775                        Cortical blindness                                               
  37800                        Esotropia, unspecified                                           
  37801                        Monocular esotropia                                              
  37805                        Alternating esotropia                                            
  37810                        Exotropia, unspecified                                           
  37815                        Alternating exotropia                                            
  37817                        Alternating exotropia with v pattern                             
  37820                        Intermittent heterotropia, unspecified                           
  37821                        Intermittent esotropia, monocular                                
  37830                        Heterotropia, unspecified                                        
  37831                        Hypertropia                                                      
  37832                        Hypotropia                                                       
  Vascular and Others          3769                                                             Unspecified disorder of orbit
  3770                         Papilledema                                                      
  37000                        Corneal ulcer, unspecified                                       
  37004                        Hypopyon ulcer                                                   
  37100                        Corneal opacity, unspecified                                     
  37120                        Corneal edema, unspecified                                       
  37142                        Recurrent erosion of cornea                                      
  37150                        Hereditary corneal dystrophy, unspecified                        
  37160                        Keratoconus, unspecified                                         
  37162                        Keratoconus, acute hydrops                                       
  37170                        Corneal deformity, unspecified                                   
  37172                        Descemetocele                                                    
  37263                        Symblepharon                                                     
  37272                        Conjunctival hemorrhage                                          
  37273                        Conjunctival edema                                               
  37274                        Vascular abnormalities of conjunctiva                            
  37275                        Conjunctival cysts                                               
  37289                        Other disorders of conjunctiva                                   
  37430                        Ptosis of eyelid, unspecified                                    
  37451                        Xanthelasma of eyelid                                            
  37482                        Edema of eyelid                                                  
  37484                        Cysts of eyelids                                                 
  37489                        Other disorders of eyelid                                        
  37515                        Tear film insufficiency, unspecified                             
  37520                        Epiphora, unspecified as to cause                                
  37521                        Epiphora due to excess lacrimation                               
  37552                        Stenosis of lacrimal punctum                                     
  37553                        Stenosis of lacrimal canaliculi                                  
  37555                        Obstruction of nasolacrimal duct, neonatal                       
  37556                        Stenosis of nasolacrimal duct, acquired                          
  37561                        Lacrimal fistula                                                 
  37630                        Exophthalmos, unspecified                                        
  37633                        Orbital edema or congestion                                      
  37646                        Enlargement of orbit                                             
  37651                        Enophthalmos due to atrophy of orbital tissue                    
  37681                        Orbital cysts                                                    
  37689                        Other orbital disorders                                          
  37700                        Papilledema, unspecified                                         
  37703                        Papilledema associated with retinal disorder                     
  37710                        Optic atrophy, unspecified                                       
  37721                        Drusen of optic disc                                             
  37724                        Pseudopapilledema                                                
  37749                        Other disorders of optic nerve                                   
  37852                        Third or oculomotor nerve palsy, total                           
  37854                        Sixth or abducens nerve palsy                                    

![Presents the flowchart for study selection.](jcm-09-01271-g001){#jcm-09-01271-f001}

![A Kaplan--Meier curve demonstrating the cumulative incidence of long-term ophthalmic morbidity in offspring exposed to preeclampsia (Log-rank test, *p* = 0.118).](jcm-09-01271-g002){#jcm-09-01271-f002}

![Kaplan--Meier curves demonstrating the cumulative incidence of long-term ophthalmic morbidity in offspring exposed to preeclampsia for each subcategory outcome: vascular and other (**A**), Log-rank test, *p* = 0.007, visual disturbance (**B**), Log-rank test, *p* = 0.303, and infection and inflammation (**C**), Log-rand test, *p* = 0.881.](jcm-09-01271-g003){#jcm-09-01271-f003}

jcm-09-01271-t001_Table 1

###### 

Clinical characteristics of the study population by exposure to maternal preeclampsia.

  --------------------------------------------------------------------------------------------------------------------
  Maternal and Newborn Characteristic   No Preeclampsia\   Mild Preeclampsia\   Severe Preeclampsia\   *p*-Value ^1^
                                        *n* = 232,841      *n* = 7279           *n* = 2222             
  ------------------------------------- ------------------ -------------------- ---------------------- ---------------
  Maternal age\                         28.13 ± 5.79       28.66 ± 6.31         29.00 ± 6.94           \<0.001
  (years, mean ± SD)                                                                                   

  Ethnicity (%)                                                                                        

  Jewish                                109,751 (47.1%)    4136 (56.8%)         978 (44.0%)            \<0.001

  Bedouins                              123,090 (52.9%)    3143 (43.2%)         1244 (56.0%)           

  Parity (%)                                                                                           

  1                                     53,348 (22.9%)     2854 (39.2%)         964 (43.4%)            \<0.001

  2--4                                  120,382 (51.7%)    2903 (39.9%)         657 (29.6%)            

  5+                                    59,060 (25.4%)     1502 (20.9%)         601 (27%)              

  Gestational age (weeks, mean ± SD)    39.17 ± 1.82       38.71 ± 1.8          36.66 ± 3.01           \<0.001

  Preterm (\<37)                        14,150 (6.1%)      701 (9.6%)           965 (43.4%)            \<0.001

  Preterm (\<34)                        2212 (1.0%)        55 (0.8%)            328 (14.8%)            \<0.001

  Low birth weight (\<2500 g)           13,668 (5.9%)      770 (10.6%)          1026 (46.2%)           \<0.001

  Apgar scores \<7 at 1 min (%)         11,035 (4.7%)      349 (4.8%)           352 (15.8%)            \<0.001
  --------------------------------------------------------------------------------------------------------------------

^1^ Data on maternal age and gestational age were evaluated using one-way analysis of variance (ANOVA) test and are presented in years as mean ± standard deviation (SD). All other data were evaluated using a Pearson chi square test and are presented in numbers and percentages.

jcm-09-01271-t002_Table 2

###### 

Long-term ophthalmic morbidity of offspring prenatally exposed to preeclampsia.

  ------------------------------------------------------------------------------------------------------------------
  Ophthalmic Morbidity                No Preeclampsia\   Mild Preeclampsia\   Severe Preeclampsia\   *p*-Value ^1^
                                      *n* = 232,841      *n* = 7279           *n* = 2222             
  ----------------------------------- ------------------ -------------------- ---------------------- ---------------
  Vascular and others                 645 (0.3%)         11 (0.2%)            12 (0.5%)              0.008

  Visual disturbance                  271 (0.1%)         7 (0.1%)             5 (0.2%)               0.286

  Infection\\inflammation             1411 (0.6%)        45 (0.6%)            12 (0.5%)              0.915

  Retinopathy of prematurity (ROP)    3 (\<0.01%)        0 (-)                1 (\<0.01%)            \<0.001

  Total ophthalmic hospitalizations   2240 (1.0%)        61 (0.8%)            29 (1.3%)              0.141
  ------------------------------------------------------------------------------------------------------------------

^1^ Data evaluated using a Pearson chi square test.

jcm-09-01271-t003_Table 3

###### 

Multivariable analyses of long-term total ophthalmic morbidity and vascular and other morbidity in offspring prenatally exposed to preeclampsia.

  Variables                                             Adjusted HR   95% CI         *p*-Value ^1^
  ----------------------------------------------------- ------------- -------------- ---------------
  **I-Total Ophthalmic Morbidity \***                                                
  No preeclampsia                                       1 (ref)                      
  Mild preeclampsia                                     0.848         0.658--1.094   0.205
  Severe preeclampsia or eclampsia                      1.358         0.941--1.959   0.102
  Maternal age (years)                                  0.995         0.988--1.003   0.206
  Ethnicity                                             0.811         0.746--0.881   \<0.001
  **II-Vascular and Other Ophthalmic Morbidity \*\***                                
  No preeclampsia                                       1 (ref)                      
  Mild preeclampsia                                     0.535         0.295--0.970   0.040
  Severe preeclampsia or eclampsia                      1.861         1.051--3.295   0.033
  Maternal age (years)                                  0.992         0.979--1.005   0.230
  Ethnicity                                             0.628         0.535--0.737   \<0.001

^1^ Data evaluated by Cox proportional hazards models. \* Model I -2Log Likelihood for total hospitalizations = 159,877. \*\* Model II -2Log Likelihood for Vascular and other = 15,926. HR, hazard ratio; CI, confidence interval.
